학술논문
A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14
Document Type
Article
Author
Rentsch, C.A.; Bosshard, P.; Püschel, H.; Thalmann, G.N.; Roth, B.; Lucca, I.; Kwiatkowski, M.; Wirth, G.J.; Strebel, R.T.; Engeler, D.; Pedrazzini, A.; Hüttenbrink, C.; Schultze-Seemann, W.; Torpai, R.; Bubendorf, L.; Wicki, A.; Boll, D.T.; Hefermehl, L.; Roghmann, F.; Gierth, M.; Ribi, K.; Schäfer, S.; Hayoz, S.
Source
In: European urology oncology . (European urology oncology, 1 April 2022, 5(2):195-202)
Subject
Language
English
ISSN
25889311